Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice.
Zeis
M
M
Department of Internal Medicine II, University of Kiel, Germany.
Uharek
L
L
Glass
B
B
Gaska
T
T
Steinmann
J
J
Gassmann
W
W
Löffler
H
H
Müller-Ruchholtz
W
W
D000818:Animals; D016026:Bone Marrow Transplantation; D002051:Burkitt Lymphoma / Q000628:therapy*; D003131:Combined Modality Therapy; D016130:Immunophenotyping; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014916:Whole-Body Irradiation
D007376:Interleukin-2